Plasma Proteomics to Identify Drug Targets and Potential Drugs for Retinal Artery Occlusion: An Integrated Analysis in the UK Biobank
Journal of Proteome Research · 2024
DOI: 10.1021/acs.jproteome.4c00044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Jiahui Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medica…. Hauptthemen laut MEDLINE: Proteomics, Retinal Artery Occlusion, Biological Specimen Banks. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Retinal artery occlusion (RAO), which is positively correlated with acute ischemic stroke (IS) and results in severe visual impairment, lacks effective intervention drugs. This study aims to perform integrated analysis using UK Biobank plasma proteome data of RAO and IS to identify potential targets and preventive drugs. A total of 7191 participants (22 RAO patients, 1457 IS patients, 8 individuals with both RAO and IS, and 5704 healthy age-gender-matched controls) were included in this study. Unique 1461 protein expression profiles of RAO, IS, and the combined data set, extracted from UK Biobank Plasma proteomics projects, were analyzed using both differential expression analysis and elastic network regression (Enet) methods to identify shared key proteins. Subsequent analyses, including single cell type expression assessment, pathway enrichment, and druggability analysis, were conducted for verifying shared key proteins and discovery of new drugs. Five proteins were found to be shared among the samples, with all of them showing upregulation. Notably, adhesion G-protein coupled receptor G1 (ADGRG1) exhibited high expression in glial cells of the brain and eye tissues. Gene set enrichment analysis revealed pathways associated with lipid metabolism and vascular regulation and inflammation. Druggability analysis unveiled 15 drug candidates targeting ADGRG1, which demonstrated protective effects against RAO, especially troglitazone (-8.5 kcal/mol). Our study identified novel risk proteins and therapeutic drugs associated with the rare disease RAO, providing valuable insights into potential intervention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
- Medical Big Data Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)Southern Medical University, 106, Zhongshan 2nd Road, Guangzhou, Guangdong Province 510080, China.
- Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou 510080, China.
ORCID-Profile: Honghua Yu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cao, J., Zhuang, M., Kong, H., Lai, C., Su, T., Liang, A., Wang, Z., Wu, Q., Fang, Y., Hu, Y., Zhang, X., Lin, M., & Yu, H. (2024). Plasma Proteomics to Identify Drug Targets and Potential Drugs for Retinal Artery Occlusion: An Integrated Analysis in the UK Biobank. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00044
Vancouver
Cao J, Zhuang M, Kong H, Lai C, Su T, Liang A, et al. Plasma Proteomics to Identify Drug Targets and Potential Drugs for Retinal Artery Occlusion: An Integrated Analysis in the UK Biobank. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.4c00044
BibTeX
@article{Cao2024,
author = {Cao, Jiahui and Zhuang, Minjing and Kong, Huiqian and Lai, Chunran and Su, Ting and Liang, Anyi and Wang, Zicheng and Wu, Qiaowei and Fang, Ying and Hu, Yijun and Zhang, Xiayin and Lin, Miao and Yu, Honghua},
title = {Plasma Proteomics to Identify Drug Targets and Potential Drugs for Retinal Artery Occlusion: An Integrated Analysis in the UK Biobank},
journal = {Journal of Proteome Research},
year = {2024},
doi = {10.1021/acs.jproteome.4c00044}
}
EUVIMED